A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gladstone Institutes · University of California, San Francisco · +20 more institutions
Indexed incrossrefdatacitepubmed
Abstract
No abstract available for this paper.
Citation impact
4,851
total citations
- FWCI
- 591.48
- Percentile
- 100%
- References
- 85
Citations per year
Authors
125- DEDavid E. GordonCorresponding
Gladstone Institutes, University of California, San Francisco, Quantitative BioSciences
- GΜGwendolyn Μ. Jang
Gladstone Institutes, University of California, San Francisco, Quantitative BioSciences
- MBMehdi Bouhaddou
Gladstone Institutes, University of California, San Francisco, Quantitative BioSciences
- JXJiewei Xu
Gladstone Institutes, University of California, San Francisco, Quantitative BioSciences
- KOKirsten Obernier
Gladstone Institutes, University of California, San Francisco, Quantitative BioSciences
Topics & keywords
Topics
Keywords
- Drug repositioning
- Coronavirus
- Druggability
- Repurposing
- Virology
- Drug
- Drug discovery
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- UDU.S. Department of DefenseAward: W81XWH
- HHHoward Hughes Medical Institute
- FHF. Hoffmann-La Roche
- ANAgence Nationale de la RechercheAwards: 10-LABX-62-IBEID, ANR-10-LABX-62-IBEID, ANR-10, grant ANR-10-LABX-62-IBEID, ANR-10-LABX-62
- NINational Institutes of HealthAwards: R01AI120694, R35GM122481, U19AI135972, W81XWH, R01AI122747, HHSN272201400008C, P50AI150476, R01AI143292, U19AI135990
- NINational Institute of Mental Health
- NINational Institute of Allergy and Infectious DiseasesAwards: R01AI143292, HHSN272201400008C, U19AI135990, U19AI135972, P50AI150476